NIH-funded research R01 grant

Why lymphatic drainage changes in inflammatory bowel disease

Official title: Mechanisms that alter lymphatic transport in inflammatory bowel disease

Funded at Washington University · NIH-11290395 · Data updated 2026-11-12

Researchers are studying how immune cells and damaged lymphatic vessels can block fluid flow in people with Crohn's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startFebruary 7, 2022
Project endJanuary 31, 2027
Funding year2026
Award (this year)$561,044
NIH project number5R01AI168044-05
Project IDNIH-11290395 on NIH RePORTER

Who could benefit from this research

Could help

People with Crohn's disease, particularly those undergoing bowel surgery or who have evidence of lymphatic inflammation, could be candidates to provide tissue samples or participate in related clinical sample studies.

Less likely to help

People without Crohn's disease or those not undergoing surgery (and thus unable to donate tissue) are unlikely to directly participate or gain immediate benefit.

What this research studies

This project uses tissue removed during surgery from people with Crohn's disease and complementary mouse models to study how B cells and their signals affect lymphatic vessels. Scientists will examine collecting lymphatic vessels and valves for tertiary lymphoid organs (TLOs) that surround and obstruct flow, and measure how lymph pressure and direction change. The team will track lymphotoxin and TNF-related signaling from B cells that may cause valve dysfunction and spur new lymphatic growth around TLOs. Findings aim to identify steps in the process that could be targeted to restore normal lymph drainage.

Why it matters

Potential benefit: If successful, this work could point to new ways to restore lymphatic drainage and reduce inflammation and symptoms in Crohn's disease.

How similar studies have gone: Previous studies have linked lymphatic damage to Crohn's disease, but specifically targeting B cell–driven lymphatic blockage and valve dysfunction is a newer, less-tested approach.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Randolph, Gwendalyn J — Washington University
  • Study coordinator: Randolph, Gwendalyn J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.